Category Specific RSS

presendin

Invex struggles to recruit patients, witnesses test failures for its clinical trial for intracranial hypertension alleviating drug

The pressure is on for biotech company Invex Therapeutics (ASX: IXC), which is not only struggling to recruit patients but…

2 years ago

Invex randomises the first patient for phase III trial of its IIH drug

Imagine a headache so intense that the literal ear-throbbing pain results in blindness or other vision impairments. Even though sometimes…

3 years ago